Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Real-world evaluation of Shujin Jianwaiwan for lumbar disc herniation and lumbar spinal stenosis
ChiCTR2300074105Phase 4Recruiting
- Sponsor
- Third Affiliated Hospital, Beijing University of Chinese Medicine
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of shujin jianwaiwan in Herniated Lumbar Disk, lumbar spinal stenosis (LSS) and lumbodynia (LBP) (2 arms), sponsored by Third Affiliated Hospital, Beijing University of Chinese Medicine. Primary endpoint: Pain VAS score. Started Dec 2022; status: recruiting.
02
Drugs
shujin jianwaiwan
03
Conditions
Herniated Lumbar Disklumbar spinal stenosis (LSS)lumbodynia (LBP)
Beyond the preview
Go deeper on ChiCTR2300074105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074105.